Argentina vs Singapore: Number of isolates tested for ceftriaxone
Argentina
285
in 2020
Singapore
232
in 2020
Argentina rank
11th
Singapore rank
13th
Number of isolates tested for ceftriaxone over time
- Argentina
- Singapore
How they compare
Argentina currently reports 285 against 232 in Singapore, a difference of 53.
That makes Argentina's figure about 1.2 times Singapore's.
Across all 11 years both countries report, Argentina has been ahead every year.
Argentina ranks 11th and Singapore ranks 13th of 52 countries.
Argentina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 310 | 160 | 150 | Argentina |
| 2010s | 618.22 | 94.11 | 524.11 | Argentina |
| 2020s | 285 | 232 | 53 | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Argentina or Singapore?
- Argentina, at 285 against 232 in Singapore as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Argentina and Singapore?
- 53, with Argentina ahead.
- How many years of comparable data are there for Argentina and Singapore?
- 11 years are reported by both, from 2009 to 2020.
- How do Argentina and Singapore rank globally for number of isolates tested for ceftriaxone?
- Argentina ranks 11th and Singapore ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.